BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Lymphoma
NCI Information
Clinical Trials
Non-Hodgkin Lymphoma Trials
Hodgkin Lymphoma Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201204004
Principal Investigator:
Bartlett, Nancy
Title:
A Phase 2 Randomized Open-label Study of MEDI-551 in Adults with Relapsed or Refractory DLBCL
Phase:
II
Disease Site:
Non-Hodgkin's Lymphoma
Participating Site(s):
Main Campus
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The overall purpose of the study is to determine if MEDI-551, when used in combination with salvage chemotherapy, Ifosfamide-carboplatin-etoposide (ICE) or Dexamethasone-cytarabine (DHAP) in patients with relapsed or refractory DLBCL who are eligible for autologous stem cell transplant (ASCT), has superior efficacy compared to rituximab in the same population.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)